Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease
Authors:
Open Access
- 22 May 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-13
Abstract
MYH9, a widely expressed gene encoding nonmuscle myosin heavy chain, is also expressed in podocytes and is associated with glomerular pathophysiology. However, the mechanisms underlying MYH9-related glomerular diseases associated with proteinuria are poorly understood. Therefore, we investigated the role and mechanism of MYH9 in diabetic kidney injury. MYH9 expression was decreased in glomeruli from diabetic patients and animals and in podocytes treated with Ang II in vitro. Ang II treatment and siRNA-mediated MYH9 knockdown in podocytes resulted in actin cytoskeleton reorganization, reduced cell adhesion, actin-associated protein downregulation, and increased albumin permeability. Ang II treatment increased NOX4 expression and ROS generation. The Ang II receptor blocker losartan and the ROS scavenger NAC restored MYH9 expression in Ang II-treated podocytes, attenuated disrupted actin cytoskeleton and decreased albumin permeability. Furthermore, MYH9 overexpression in podocytes restored the effects of Ang II on the actin cytoskeleton and actin-associated proteins. Ang II-mediated TRPC6 activation reduced MYH9 expression. These results suggest that Ang II-mediated MYH9 depletion in diabetic nephropathy may increase filtration barrier permeability by inducing structural and functional podocyte injury through TRPC6-mediated Ca2+ influx by NOX4-mediated ROS generation. These findings reveal a novel MYH9 function in maintaining urinary filtration barrier integrity. MYH9 may be a potential target for treating diabetic nephropathy.Keywords
Funding Information
- National Research Foundation of Korea (2018R1A6A3A11040860, 2015R1A6A1A03032522, 2017R1D1A3B03027898)
- Korea Health Industry Development Institute (HI17C-2059-010017)
- Soonchunhyang University
This publication has 51 references indexed in Scilit:
- Polymorphisms in MYH9 are associated with diabetic nephropathy in European AmericansNephrology Dialysis Transplantation, 2011
- Antagonistic Regulation of Actin Dynamics and Cell Motility by TRPC5 and TRPC6 ChannelsScience Signaling, 2010
- African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic AmericansHuman Molecular Genetics, 2010
- Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15Human Molecular Genetics, 2010
- Non-muscle myosin II takes centre stage in cell adhesion and migrationNature Reviews Molecular Cell Biology, 2009
- Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRDNephrology Dialysis Transplantation, 2009
- MYH9 is associated with nondiabetic end-stage renal disease in African AmericansNature Genetics, 2008
- MYH9 is a major-effect risk gene for focal segmental glomerulosclerosisNature Genetics, 2008
- TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionNature Genetics, 2005
- Positionally Cloned Gene for a Novel Glomerular Protein—Nephrin—Is Mutated in Congenital Nephrotic SyndromeMolecular Cell, 1998